Lynx1 Capital Management as of June 30, 2023
Portfolio Holdings for Lynx1 Capital Management
Lynx1 Capital Management holds 18 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 19.9 | $30M | 1.2M | 26.33 | |
| Cabaletta Bio (CABA) | 18.5 | $28M | 2.2M | 12.91 | |
| Alpine Immune Sciences (ALPN) | 18.0 | $28M | 2.7M | 10.28 | |
| Cymabay Therapeutics | 8.6 | $13M | 1.2M | 10.95 | |
| Tscan Therapeutics (TCRX) | 8.6 | $13M | 5.2M | 2.50 | |
| Gh Research Ordinary Shares (GHRS) | 7.5 | $12M | 969k | 11.87 | |
| Pardes Biosciences | 4.6 | $7.1M | 3.9M | 1.81 | |
| Theseus Pharmaceuticals | 4.6 | $7.1M | 757k | 9.33 | |
| Kinnate Biopharma (KNTE) | 4.1 | $6.2M | 2.0M | 3.03 | |
| Neoleukin Therapeutics | 1.7 | $2.6M | 3.1M | 0.83 | |
| Pieris Pharmaceuticals (PIRS) | 1.1 | $1.6M | 9.8M | 0.17 | |
| Cullinan Oncology (CGEM) | 0.8 | $1.2M | 115k | 10.76 | |
| Passage Bio (PASG) | 0.7 | $1.1M | 1.2M | 0.94 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.6 | $956k | 23k | 41.57 | |
| Athira Pharma (ATHA) | 0.4 | $571k | 194k | 2.95 | |
| Pharvaris N V (PHVS) | 0.2 | $321k | 21k | 15.14 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $167k | 20k | 8.28 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.0 | $35k | 18k | 1.90 |
